Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease.

Keeling BH, Vilariño-Güell C, Ross OA, Wszolek ZK, Uitti RJ, Farrer MJ.

Neurosci Lett. 2009 Sep 18;461(2):74-5. doi: 10.1016/j.neulet.2009.05.084. Epub 2009 Jun 12.

2.

Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence.

Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J.

Alcohol Clin Exp Res. 2008 Dec;32(12):2117-27. doi: 10.1111/j.1530-0277.2008.00800.x. Epub 2008 Sep 30.

3.

Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample.

Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD.

Neuropsychopharmacology. 2009 Jan;34(2):319-30. doi: 10.1038/npp.2008.37. Epub 2008 Mar 19.

4.

Polymorphism in environment responsive genes and association with Parkinson disease.

Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D.

Mol Cell Biochem. 2008 May;312(1-2):131-8. doi: 10.1007/s11010-008-9728-2. Epub 2008 Mar 9.

PMID:
18327668
5.

Pooled analysis of tobacco use and risk of Parkinson disease.

Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J.

Arch Neurol. 2007 Jul;64(7):990-7.

PMID:
17620489
6.

Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study.

Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Soderkvist P, Felice A; Geoparkinson Study Group.

Occup Environ Med. 2007 Oct;64(10):673-80. Epub 2007 Apr 20.

7.

Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.

Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L.

Hum Mol Genet. 2006 Dec 15;15(24):3498-507. Epub 2006 Nov 3.

PMID:
17085484
8.

Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data.

Fung HC, Scholz S, Matarin M, Simón-Sánchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodríguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A.

Lancet Neurol. 2006 Nov;5(11):911-6.

PMID:
17052657
9.

Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.

Juyal RC, Das M, Punia S, Behari M, Nainwal G, Singh S, Swaminath PV, Govindappa ST, Jayaram S, Muthane UB, Thelma BK.

Neurogenetics. 2006 Nov;7(4):223-9. Epub 2006 Jul 1. Erratum in: Neurogenetics. 2008 Feb;9(1):73.

PMID:
16816977
10.
11.

Clinical characteristics in early Parkinson's disease in a central California population-based study.

Kang GA, Bronstein JM, Masterman DL, Redelings M, Crum JA, Ritz B.

Mov Disord. 2005 Sep;20(9):1133-42.

12.

Progress in searching for susceptibility loci and genes for smoking-related behaviour.

Li MD, Ma JZ, Beuten J.

Clin Genet. 2004 Nov;66(5):382-92. Review.

PMID:
15479180
13.

The genetic basis for smoking behavior: a systematic review and meta-analysis.

Munafò M, Clark T, Johnstone E, Murphy M, Walton R.

Nicotine Tob Res. 2004 Aug;6(4):583-97. Review.

PMID:
15370155
14.
15.

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM.

Am J Epidemiol. 2003 Jun 1;157(11):1015-22.

PMID:
12777365
16.

Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.

Tan EK, Tan Y, Chai A, Tan C, Shen H, Lum SY, Fook-Cheong SM, Teoh ML, Yih Y, Wong MC, Zhao Y.

Mov Disord. 2003 May;18(5):593-5.

PMID:
12722176
17.

D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes.

Noble EP.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):103-25. Review.

PMID:
12497624
18.

Polymorphisms in dopamine receptors: what do they tell us?

Wong AH, Buckle CE, Van Tol HH.

Eur J Pharmacol. 2000 Dec 27;410(2-3):183-203. Review.

PMID:
11134669
19.

Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease.

Grevle L, Güzey C, Hadidi H, Brennersted R, Idle JR, Aasly J.

Mov Disord. 2000 Nov;15(6):1070-4.

PMID:
11104188
20.

Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.

Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H.

J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):535-7.

Supplemental Content

Support Center